Kyogoku unyu shoji
9073
BlueMeme
4069
Estore
4304
Visumo
303A
D. Western Therapeutics Institute
4576
JP Stock MarketDetailed Quotes
4256 Cynd
- 1098
- +21+1.95%
20min DelayMarket Closed Dec 30 15:30 JST
6.37BMarket Cap178.54P/E (Static)
1113High1078Low9.90KVolume1078Open1077Pre Close10.88MTurnover131552wk High0.89%Turnover Ratio5.80MShares60552wk Low16.66EPS TTM1.22BFloat Cap3370Historical High178.54P/E (Static)1.11MShs Float605Historical Low6.15EPS LYR3.25%Amplitude--Dividend TTM1.96P/B100Lot Size--Div YieldTTM
Cynd News
Cynd: Half Year Report - Term 14 (2024/04/01 - 2025/03/31)
Cynd: Confirmation letter
Cynd: 2nd Half (Mid-Term) Decision SMS for March 2025 [Japan Basis] (link)
Cynd: Presentation of financial results for the 2nd quarter of the fiscal year ending March 31, 2025
Cynd: 1st quarter financial results for the March 2025 period (consolidated) based on Japanese standards.
Cynd: Financial report for the first quarter ending in March 2025.
Cynd: Interim report
Cynd: Confirmatory letter.
Cynd: Financial Report - 13th Term (2023/04/01 - 2024/03/31)
CYND: (Correction) Partial Corrections to “Financial Results Presentation Materials for the Fiscal Year Ending March 31, 2024”
CYND: Financial results presentation materials for the fiscal year ending March 2024
CYND: Notice regarding differences between full-year consolidated earnings forecasts and actual results
CYND: Summary of Financial Results for the Fiscal Year Ending March 31, 2024 [Japanese GAAP] (Consolidated)
Signed: Quarterly Report - 13th Quarter (2023/10/01 - 2023/12/31)
Signed: Confirmation
Cynd: Presentation of financial results for the 3rd quarter of the fiscal year ending March 31, 2024
Cynd: Notice regarding revisions to full-year consolidated earnings forecasts
Cynd: Summary of Financial Results for the 3rd Quarter Ending March 31, 2024 [Japanese GAAP] (Consolidated)
Cynd: Confirmation letter
Cynd: Quarterly Report - 13th Second Quarter (2023/07/01 - 2023/09/30)